3FZ Stock Overview
Engages in the manufacture and sale of ingredients for cosmetic industry in Norway. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aqua Bio Technology ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 0.14 |
| 52 Week High | NOK 0.60 |
| 52 Week Low | NOK 0.13 |
| Beta | 0.68 |
| 11 Month Change | -38.64% |
| 3 Month Change | -51.61% |
| 1 Year Change | -43.51% |
| 33 Year Change | -89.89% |
| 5 Year Change | n/a |
| Change since IPO | -92.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3FZ | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -17.7% | -0.1% | 1.1% |
| 1Y | -43.5% | -0.6% | 7.2% |
Return vs Industry: 3FZ underperformed the German Chemicals industry which returned -0.5% over the past year.
Return vs Market: 3FZ underperformed the German Market which returned 8.6% over the past year.
Price Volatility
| 3FZ volatility | |
|---|---|
| 3FZ Average Weekly Movement | 10.7% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3FZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 3FZ's weekly volatility has decreased from 20% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 4 | Havard Lindstrom | aquabiotechnology.com |
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics.
Aqua Bio Technology ASA Fundamentals Summary
| 3FZ fundamental statistics | |
|---|---|
| Market cap | €15.83m |
| Earnings (TTM) | -€128.54k |
| Revenue (TTM) | €1.18m |
13.4x
P/S Ratio-123.1x
P/E RatioIs 3FZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3FZ income statement (TTM) | |
|---|---|
| Revenue | NOK 13.82m |
| Cost of Revenue | NOK 4.50m |
| Gross Profit | NOK 9.32m |
| Other Expenses | NOK 10.82m |
| Earnings | -NOK 1.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 67.43% |
| Net Profit Margin | -10.88% |
| Debt/Equity Ratio | 264.7% |
How did 3FZ perform over the long term?
See historical performance and comparison